KP Tissue Inc.
KPTSF
$7.80
$0.030.39%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- |
| Operating Income | -- | -- | -- | -- | -- |
| Income Before Tax | 226.13% | -41.59% | -30.12% | -57.25% | 410.39% |
| Income Tax Expenses | -- | -74.68% | -74.68% | -74.68% | -98.68% |
| Earnings from Continuing Operations | 233.26% | -40.48% | -28.54% | -56.71% | 150.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 233.26% | -40.48% | -28.54% | -56.71% | 150.25% |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 232.01% | -40.69% | -28.75% | -56.81% | 150.12% |
| Normalized Basic EPS | 307.22% | -41.73% | -26.45% | -57.64% | 203.02% |
| EPS Diluted | 232.01% | -40.69% | -28.75% | -56.81% | 150.12% |
| Normalized Diluted EPS | 307.22% | -41.73% | -26.45% | -57.64% | 203.02% |
| Average Basic Shares Outstanding | 0.27% | 0.26% | 0.24% | 0.23% | 0.21% |
| Average Diluted Shares Outstanding | 0.27% | 0.26% | 0.24% | 0.23% | 0.21% |
| Dividend Per Share | -1.96% | -2.74% | -2.90% | -3.09% | -1.50% |
| Payout Ratio | -0.71% | 0.63% | 0.36% | 1.23% | 2.96% |